Literature DB >> 32663063

RNA polymerase II-binding aptamers in human ACRO1 satellites disrupt transcription in cis.

Jennifer L Boots1, Frederike von Pelchrzim1, Adam Weiss1, Bob Zimmermann1, Theres Friesacher2, Maximilian Radtke1, Marek Żywicki3, Doris Chen1, Katarzyna Matylla-Kulińska1, Bojan Zagrovic2, Renée Schroeder1.   

Abstract

Transcription elongation is a highly regulated process affected by many proteins, RNAs and the underlying DNA. Here we show that the nascent RNA can interfere with transcription in human cells, extending our previous findings from bacteria and yeast. We identified a variety of Pol II-binding aptamers (RAPs), prominent in repeat elements such as ACRO1 satellites, LINE1 retrotransposons and CA simple repeats, and also in several protein-coding genes. ACRO1 repeat, when translated in silico, exhibits ~50% identity with the Pol II CTD sequence. Taken together with a recent proposal that proteins in general tend to interact with RNAs similar to their cognate mRNAs, this suggests a mechanism for RAP binding. Using a reporter construct, we show that ACRO1 potently inhibits Pol II elongation in cis. We propose a novel mode of transcriptional regulation in humans, in which the nascent RNA binds Pol II to silence its own expression.

Entities:  

Keywords:  RNA aptamers; RNA polymerase II; Transcription; regulatory RNAs; repeats; silencing

Year:  2020        PMID: 32663063      PMCID: PMC7714431          DOI: 10.1080/21541264.2020.1790990

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


Introduction

Control of gene expression is essential for all living organisms to coordinate growth and development. Transcription, as the first step, is tightly regulated, and RNA polymerase II (Pol II) progression along the gene is not smooth. Pol II pauses in the promoter-proximal region and also during elongation [1-3]. The dynamics of the elongating Pol II vary on a gene-by-gene basis suggesting that the underlying gene sequence is a relevant factor for transcription efficiency [1,4]. A large number of protein factors regulate transcription in various ways and, recently, several RNAs have been identified that interfere with transcription via diverse mechanisms, either indirectly (e.g., long non-coding RNAs affecting transcription by changing chromatin structure and function [5]), or by directly interacting with the transcription machinery [6-8]. To date, only two naturally occurring trans-acting RNAs have been reported to directly bind to RNA polymerase and inhibit transcription in eukaryotes [7,8]: mouse B2 and human Alu RNAs are induced by stress [9] and downregulate initiation of Pol II transcription at promoters [8]. In addition, an in vitro selected RNA, the FC aptamer, is able to inhibit transcription of yeast Pol II in vitro by binding to the active center cleft [10]. Certain RNAs are also able to serve as a template for an ancient RNA-dependent RNA polymerase activity of Pol II [11-13]. A less-explored field is the impact of cis-acting nascent RNA-borne signals on transcription. Bacterial riboswitches, located in the 5ʹ untranslated regions of mRNAs, can dynamically refold in response to ligand binding or temperature shift and promote transcription elongation or termination [14,15]. Similarly, eukaryotic Pol II activity has been shown to be affected by secondary structure in the nascent RNA. Specifically, stable structural elements inhibit backtracking, which leads to decreased rate of pausing and increased rate of transcription [16]. Furthermore, nascent RNAs can bind and trap transcription factors to the site of transcription contributing to their association with cognate DNA elements [17]. Alternatively, nascent transcripts can recruit proteins that cause transcription attenuation [15]. For example, the recognition motifs of Nrd1 and Nab3, components of a yeast transcription terminator complex are enriched in ncRNAs but depleted from mRNAs [15,18]. Our laboratory has shown that nascent RNA can regulate transcription by direct binding to the transcribing polymerase in Escherichia coli and Saccharomyces cerevisiae [19,20]. Short CA-rich elements within the emerging RNA, which we called RNA polymerase-binding aptamers (RAPs), potently attenuate transcription of their host genes, or increase the expression of antisense genes by suppressing transcriptional interference [21]. In this work, we extend the findings from bacteria and yeast and show that human Pol II is amenable to regulation by RAPs in the nascent RNA as well. We performed a genomic SELEX experiment to look for RAPs encoded in the human genome. We focus on one of the most highly enriched SELEX sequences derived from ACRO1 satellites and show that ACRO1-derived RAPs are potent self-silencing elements.

Results

Genomic SELEX identifies Pol II-binding aptamers encoded in the human genome

We constructed an RNA library [22] representing the human genome in short (30–400 nt) transcripts and screened it for high-affinity binding to a purified complete Pol II 12-subunit complex from S. cerevisiae, since human Pol II could not be obtained in sufficient purity and quantity. Due to the high degree of conservation of the enzyme [23] and the fact that murine B2 RNA is able to bind to the S. cerevisiae Pol II core [24], we assumed that the binding sites for other RNAs might also be conserved. In the course of the SELEX procedure (Figure 1(a)), Pol II-binding RNAs started to enrich in the 4th cycle (Figure 1(b)) showing that the vast majority of RNAs in the starting pool do not bind to Pol II. We enforced higher stringency in the 6th and 7th cycles by lowering the protein concentration, thereby increasing the RNA-to-protein ratio in order to select sequences that bind in the low nanomolar range.
Figure 1.

Genomic SELEX for RNA polymerase II-binding elements (RAPs)

Genomic SELEX for RNA polymerase II-binding elements (RAPs) We selected 200 clones from the 7th cycle for Sanger-sequencing which resulted in 74 individual RNAs. We validated the selection by showing that a set of exemplary RNAs from the 7th SELEX cycle are expressed in HeLa cells (SI Fig. S1A), bind human Pol II in vitro (SI Fig. S1B) and can be co-immunoprecipitated with Pol II from HeLa lysates (Fig. 1(c)), vindicating our assumption that yeast and human Pol II share cognate RNAs. The predominant RNA species among the 200 individually cloned aptamers were derived from repeat regions, such as LINEs, SINEs and satellites. These findings show that the successfully selected RNAs bind to Pol II in their natural context. Binding of total RNA from the 7th cycle pool to purified human Pol II can be partially outcompeted by B2 RNA; thus, a fraction of RAPs presumably interact with the Pol II active site (SI Fig. S1C) [24].

RAPs are found throughout the human genome, most notably in repeat regions

Although the selection procedure resulted in the successful isolation of RNAs binding to Pol II, no significantly enriched sequence was observed in the small sample of 200 clones, suggesting that the pool from the 7th cycle contained many diverse sequences. Therefore, we subjected this enriched pool to deep sequencing and computational analysis (Figure 2). Enriched RNAs were mapped uniquely or multiple times to the genome (SI Fig. S2A). The unique hits were enriched in genic and intergenic regions, in sense as well as antisense orientation relative to the coding strand. The most prominently enriched RAP 5765 maps to the sense strand of intron 13 of the MARK4 gene on chromosome 19 (Table 1). The majority of sequences, however, mapped to repeat regions and their enrichment was normalized according to their frequency in the human genome (Table 2). The enriched RNAs did not contain one single dominant sequence or structural motif, suggesting that Pol II can bind a variety of diverse RNA molecules. Generally, RAPs were more CA-rich than expected by chance (SI Fig. S2B), which is consistent with our observations in E. coli and S. cerevisiae [19,20], and the highest enrichment score among the repeats was reached by (CACA/TC/A)n simple repeats and the ACRO1 family of satellites.
Figure 2.

Schematic of the workflow for the selection and the analysis of RAPs

Table 1.

Top uniquely mapped genic PBEs

PBE IDGeneChromosomeRead countLength (nt)Orientationa
5765Microtubule affinity-regulating kinase 4 (MARK4)19948113Sense
141Histone deacetylase 1 (HDAC1)167451Anti
858Microtubule affinity-regulating kinase 1 (MARK1)159442Anti
10,384Guanylyl cyclase-activating protein 1 (GUCA1A)653558Anti
933Probable saccharopine dehydrogenase (SCCPDH)1401105Sense
2312Voltage-dependent L-type calcium channel subunit alpha-1 C (CACNA1 C)1226191Anti
122Sodium/hydrogen exchanger 1 (SLC 9A1)124760Anti
6885Disintegrin and metalloproteinase domain containing protein 33 (ADAM33)2024440Sense
5920Hippocalcin like protein 1 (HPCAL1)29234Sense
90Immunoglobulin superfamily member 21 (IGSF21)18658Anti

arelative to mRNA strand

Table 2.

Top repeat-derived RAPs

  Number of Mappings
  
Repeat typeRepeat familySenseAntisenseFold enrichmenta,b 
Simple repeat(CACAC)n13932652152 
SatelliteACRO1102911274 
Simple repeat(CACCAT)n202020944 
LINE1L1HAL-2a MD24988566 
DNAhAT-Charlie1180202 
 (CA)n12,7621800131 
     
LINEL1HSc214945 

aenrichment of the more prominent strand normalized to the abundance in the genomea enrichment of the more prominent strand normalized to the abundance in the genome

bthe enrichment should be understood as approximation, since the number of repeat loci is unlikely to be the same in the source and reference genomesb the enrichment should be understood as approximation, since the number of repeat loci is unlikely to be the same in the source and reference genomes

cL1HS is listed here because of its regulatory properties described previously (see text)c L1HS is listed here because of its regulatory properties described previously (see text)

Schematic of the workflow for the selection and the analysis of RAPs Top uniquely mapped genic PBEs arelative to mRNA strand Top repeat-derived RAPs aenrichment of the more prominent strand normalized to the abundance in the genomea enrichment of the more prominent strand normalized to the abundance in the genome bthe enrichment should be understood as approximation, since the number of repeat loci is unlikely to be the same in the source and reference genomesb the enrichment should be understood as approximation, since the number of repeat loci is unlikely to be the same in the source and reference genomes cL1HS is listed here because of its regulatory properties described previously (see text)c L1HS is listed here because of its regulatory properties described previously (see text)

ACRO1 satellites

The ACRO1 consensus repeat unit is 147 bp long and occurs as 1.3–2.4 kb and 256 bp long arrays within a 6 kb higher-order repeat structure containing portions of LINEs, LTRs and DNA transposons. We termed these higher-order repeats “ACREs” for ACRO1-containing repeat elements (Figure 3(a) and SI Fig. S3A). While ACREs are partially or fully conserved among all sequenced primates (SI Fig. S3B), no non-primate organism was found to carry a homologue of the ACRO1 repeat. ACRO1 satellites are moderately abundant, tandem paralogue repeat elements clustered in the pericentromeric region of chromosome 4 and dispersed on chromosomes 1, 2, 19 and 21 (Figure 3(b,c)). In addition, many ACRO1 satellites have been mapped by FISH to chromosome 3 and to the acrocentric chromosomes 13, 14, 15, and 22 [25], but these regions remain to be annotated. Figure 3(d) shows SELEX read stacks mapping to the ACRO1 consensus unit defining the Pol II-binding region. These read stacks cover the ACRO1 RAPs, which are not individual bona fide transcripts, but rather domains within longer RNAs with Pol II-binding potential. We were unable to detect stable transcripts derived from ACRO1 satellites in HeLa cells. Nevertheless, ACRO1 satellites have been reported to be expressed at very low levels in several epithelial cancers [26] and early-stage human embryos [27].
Figure 3.

The structure and distribution of ACRO1 satellites

The structure and distribution of ACRO1 satellites We noticed that ACRO1 satellites are rich in codons for amino acids present in the Pol II subunit 1 CTD, especially proline, serine and threonine. When the ACRO1 consensus sequence was translated in silico into protein and aligned globally with a fragment of Pol II CTD, 23 out of 49 amino acids were identical (e-value = 1.9 x 10−15, see Methods) and most convincingly also reflected the repetitive nature of the heptapeptide repeat (Figure 3(e)). Furthermore, the ACRO1 RAPs harbor part of the sequence previously identified in a random SELEX experiment that binds to the Pol II CTD with an estimated KD of 600 nM [28]. This is reminiscent of the stereochemical hypothesis of genetic code origin that suggests that the code evolved in part from direct binding preferences between amino acids and their codons [29-31]. Recently, we have extended this hypothesis to suggest that proteins, especially if unstructured, might in general bind specifically to RNAs that share codon composition with their mRNAs [32-35]. We therefore also translated all the enriched human RAPs into amino acids in all three 5ʹ→3ʹ reading frames and, surprisingly, found a strong bias for amino acids proline, serine and threonine, which are present in the Pol II CTD heptapeptide repeat YSPTSPS (Figure 3(f)). The high statistical significance of this bias (p-value < 10−23) was ascertained by comparing the RAP-derived amino-acid frequencies to those derived from random RNA sequences, all normalized to the respective number of codons in the genetic code (see Methods for details).

LINE1 retrotransposons are rich in RAPs

Another class of repeats prominent in our selection were the LINE elements, which was especially interesting because they had previously been reported to disrupt their own expression [36]. There are multiple RAPs located within the 4 kb LINE1 ORF2 sequence (Figure 4(a)). LINEs were shown to inhibit transcription when introduced into a reporter construct (Figure 4(b)) and transfected into HeLa cells [36]. In the study by Han et al., it was not possible to narrow down the sequences responsible for disruption of transcription, though the effect was clearly dependent on the length of the LINE sequence. These results possibly indicate that LINEs contain sequences reducing their expression to avoid active invasion and damage of the genome caused by retrotransposition. The fact that RAPs were especially enriched in active full-length LINEs supports this hypothesis (SI Fig. S4). We repeated the above-mentioned experiments and analyzed the role of RAPs in LINE silencing. As can be seen in Figure 4(c), the presence of ORF2 abrogated transcription of the reporter gene (L1), and elimination of the flanking RAPs led to a partial recovery (L1BS). These results corroborate the notion that sequences within the LINE1 ORF2 interfere with its expression. The fact that these sequences were enriched in the SELEX experiment suggests that the silencing is mediated by interaction with Pol II.
Figure 4.

RAPs induce transcriptional silencing

RAPs induce transcriptional silencing

RAPs disrupt transcription in cis

Encouraged by this observation, we used the same system to test whether highly enriched RAPs, such as ACRO1 repeats and RAP 5765, could also lead to transcriptional disruption. Single RAPs inserted into the GFP-LacZ reporter system had no or only a minor effect on steady-state RNA levels (Figure 4(d)). However, insertion of multiple ACRO1 repeat units into the reporter resulted in a strong transcriptional disruption. A short insert of 0.3 kb containing two ACRO1-derived RAPs already had a visible effect, and ACRO1 insertion of 1.1 and 1.4 kb almost completely eliminated the RNA product (Figure 4(f) and SI Fig. S5). When multiple RAPs of the highly enriched genic 5765 aptamer were cloned in tandem, they severely disrupted transcription of the GFP reporter and the number of RAPs correlated with the extent of transcriptional repression (Figure 4(e) and SI Fig. S5). This down-regulating effect of the RAPs was alleviated when reverse complement sequences were used as controls confirming sequence and/or structural specificity and ruling out the possibility that a trans-acting DNA-binding factor constitutes a roadblock to transcription. We further focused our analysis on ACRO1 satellites and asked whether the promoter has an impact on the transcriptional downregulation mediated by RAPs. Replacing the CMV with the alpha-globin promoter in the GFP-LacZ reporter resulted in similarly depleted GFP expression levels (Figure 4(g)). In addition, co-transfecting both ACRO1 and control plasmids led to full RNA levels indicating that RAPs did not have an effect on the cognate locus in trans (Figure 4(h)). It is thus possible that RAPs either regulate their expression co-transcriptionally or affect the stability of the mature RNA. To distinguish between post- and co-transcriptional regulation, we monitored transcript levels upstream and downstream of the ACRO1 insertion by RT-qPCR (Figure 5(a)). We compared the amount of RNA three loci upstream and three loci downstream of the ACRO1 insert. The decrease of the downstream RNA levels in ACRO1-containing construct, but not in reverse complement (ORCA) or no-insert (-ins) controls, indicates that RNA production was compromised at the ACRO1 locus. Next, we repeated the experiment with separated Poly(A)+ and Poly(A)- fractions of total RNA (SI Fig. S6A). We reasoned that the Poly(A)- fraction contained incomplete products of ongoing transcription and could thus uncover true co-transcriptional regulatory events, whereas the Poly(A)+ fraction contained full-length RNAs that escaped the regulation (SI Fig. S6B). Indeed, the RNA profile in the Poly(A)+ fraction was comparable between ACRO1 construct and controls, but the downstream RNA strongly decreased in the Poly(A)- fraction indicating that RAPs have no impact on the fate of the mature full-length transcript (Figure 5(b,c)). These results show that the RAP-mediated inhibition is co-transcriptional, spatially restricted to the vicinity of the RAP template and that RAP-containing RNAs are stable once fully transcribed.
Figure 5.

Autoregulation of RAPs is co-transcriptional

Autoregulation of RAPs is co-transcriptional To test whether individual RAPs exert transcriptional repression in their endogenous context, we took the same approach to quantify transcript levels upstream and downstream of the most highly enriched genic RAP 5765 within the MARK4 gene intron 13 (Figure 5(d)). The results show a moderate decrease of downstream RNA indicating that even a single RAP can modulate transcriptional output in its endogenous context.

Discussion

Genomic SELEX is a powerful tool to extract silencing information from genomes

Transcription is a central process in cellular life, and its regulation occurs at multiple levels. The number of proteins known to interfere with this process is large. Recently, we showed that RNA can also be a potent regulator of transcription, and that the nascent RNA contains signals that communicate with the transcription machinery in bacteria and yeast [19,20]. Genomic SELEX using the complete genomic DNA as source of RNA and purified RNA polymerase as bait proved to be a powerful approach in this context because this procedure is unbiased and also includes DNA sequences that are expressed at a very low level or not at all in vivo [37]. Using genomic SELEX and human genomic DNA we identified a large number of human Pol II aptamers (RAPs) encoded throughout the human genome both in unique and, most prominently, in repetitive elements. RAPs do not constitute a single RNA family with one common motif or structure, although they are generally CA-rich. RAPs are very diverse suggesting that there are many different ways that RNAs can interact with Pol II, perhaps not surprisingly, as the Pol II complex is very large and contains many potential interaction sites on its surface and in its active site. The yeast Pol II active center has been shown to be very flexible and able to accommodate quite large RNAs [24], and a cryo-EM analysis of the mammalian Pol II showed high degree of similarity between the two enzymes [38]. It should be noted, however, that by using the yeast Pol II as bait we might have missed human RAPs that do not bind to fragments conserved in the two homologues.

When translated, ACRO1 satellites resemble Pol II CTD sequence

Recently, we have demonstrated that nucleobase-density profiles of typical mRNA coding sequences match closely the nucleobase-affinity profiles of their cognate proteins, with anti-matching seen only in the case of adenine profiles [32-35]. This finding generalized the stereochemical hypothesis of the origin of the genetic code [29-31], and suggested that proteins, especially if unstructured, may bind in a co-aligned, complementary fashion to their cognate mRNAs, but also other RNAs that share features with their mRNAs [32-35]. In direct support of this proposal, here we could show that, remarkably, ACRO1 satellites encode a protein sequence similar to the Pol II CTD and that, in addition, the RAPs are enriched in codons for the amino acids proline, serine and threonine, which feature heavily in the Pol II CTD sequence (Figure 3(e,f)). This, in turn, allows us to propose that the mechanism of RAP binding to Pol II may in part involve direct interactions between the codons contained in RAPs with their corresponding amino acids in Pol II and, especially, its CTD. Further analysis of these exciting possibilities is warranted. Furthermore, it is possible that ACRO1 repeats are evolutionarily derived from the Pol II CTD mRNA to introduce an additional level of transcription regulation close to centromeres. ACRO1 elements are moderately abundant in the human genome and are mainly located in pericentromeric regions which are transcriptionally inactive. Their mobility could have been provided by the mobile elements contained within the ACREs (SI Fig. S3A). This would be a very recent acquisition as they can only be found in primates. If ACRO1 RNA binds to CTD because of a mutual relationship on the codon level, why does the CTD mRNA itself not appear among RAPs? As mentioned above, adenine is the only nucleotide with anti-matching density and affinity profiles, i.e., adenine-rich codons tend not to bind cognate residues [33,35,39]. This suggests that the affinity between codons and their cognate amino acids could be attenuated or even reversed with increasing adenine density. Indeed, the ACRO1 density profile is an inverse of that of the CTD mRNA and matches the CTD adenine-affinity profile, providing a potential explanation for why ACRO1 could bind to Pol II CTD, while the CTD’s mRNA would not (SI Fig. S7).

RAPs represent a novel type of regulatory RNA signals

In this work, we identified a novel level of transcription regulation in human cells by showing that RNA signals on the nascent RNA can interfere with the transcribing Pol II in cis, abrogating transcription. It has already elegantly been shown that the secondary structure of the nascent RNA affects the rate of Pol II transcription in vitro by inhibiting backtracking and thus preventing the polymerase to escape from pausing [16]. RAPs are RNA sequences that were enriched in a SELEX procedure due to their virtue of binding to Pol II. They are not bona fide transcripts but rather domains within potentially expressed RNAs that convey Pol II-binding capacity to their host transcripts. In the context of our experiments, RAPs are part of the nascent transcript interacting with Pol II in cis during transcription. We observed that their effect on transcription is additive and that the more RAPs are present on the nascent RNA the stronger the inhibitory effect (Figure 4(e,f)). Most importantly, the inhibitory effect is co-transcriptional. Once the RNA is fully transcribed, RAPs have no impact either on transcription or on the stability of the transcript (Figure 5(a–c)). Based on these observations, we hypothesize that the nascent RNA can cross-talk to Pol II via many potential interaction sites on its surface, or via the CTD, and thereby disrupt transcription (Figure 5(e)). Recently, circular intronic long noncoding RNAs were shown to accumulate at the site of transcription, associate with the elongating RNA polymerase and act as positive regulators of transcription [40]. Here we add another layer of transcriptional regulation that involves cis-acting sequences within the nascent transcript that affects transcription elongation. This might be an essential self-regulatory strategy for repeat elements to stay silent, enabling their survival in the genome during evolution. In addition, we hypothesize that RAP-mediated control of transcription might play a role in gene-regulatory processes, which depend on the rate of Pol II progression, such as alternative splicing and termination [41]. Indeed, several RAPs map downstream of alternative splice sites and alternative polyadenylation sites (not shown).

RAP-mediated transcription termination is a conserved phenomenon from bacteria to yeast to humans

In this work, we have presented evidence that Pol II can “sense” the nature of transcripts by means of direct interaction and that some RNA sequences encoded in the human genome have the potential to interfere with their own transcription in cis. We propose a novel mode of transcriptional control in human cells, wherein the nascent RNA binds to the transcribing Pol II making it elongation-incompetent (Figure 5(e)). Similar screens have been performed for the E. coli genome and the bacterial RNA polymerase and the yeast S. cerevisiae genome and yeast Pol II [19-21]. E. coli RAPs cause Rho-dependent premature transcription termination by uncoupling translation and transcription, or induction of genes on the opposite strand by attenuating transcriptional interference. Likewise, yeast RAPs induce premature transcription termination demonstrating that RAP-mediated transcription interference is a conserved phenomenon. A cross-talk between the nascent RNA and the transcription machinery could provide the primary signal that determines the fate of transcripts.

Materials & methods

Library construction and Genomic SELEX

The genomic library was created as described previously [37], with human genomic DNA purchased from Sigma (CAS number 9007–49-2) as template. After transcribing the genomic library into RNA, the RNA pool was bound to Pol II of S. cerevisiae in an in vitro binding reaction as described in ref [22]. For the 1st-5th cycles, RNA was added at 1 µM and protein at 100 nM. To increase stringency and competition, RNA was added at 1 µM and protein at 10 nM for the 6th and 7th cycles. The binding buffer contained 10 mM HEPES pH 7.25, 40 mM NH4SO4, 10 µM ZnCl2, 1 mM KCl, 10 mM DTT, 5% glycerol and 10 mM MgCl2.

Co-immunoprecipitation

HeLa cells grown in 10 cm dishes were harvested at 80% confluence with 1 ml lysis buffer (10 mM HEPES pH 7.0, 100 mM KCl, 5 mM MgCl2, 0.5% Nonidet P-40, 1 mM DTT, 100 U/ml RNAse inhibitor (Promega), 2 mM vanadyl ribonucleoside complexes solution, 25 µl/ml protease inhibitor cocktail for mammalian tissues) per 10 cm−1 and removed from the dish with a cell scraper. After 10 min on ice cells were centrifuged at 4°C, 1000 × g. Whole cell extracts were prepared for co-IP as described [42]. RNA purified from the immunoprecipitates and input RNA were analyzed by RT-PCR with the Qiagen RT-PCR kit using primers specific for the different RNAs.

Antibodies

Pol II and DNA polymerase antibodies were purchased from Abcam (ab817/ab5408 and ab3181, respectively). Pol II antibody recognizes the phosphorylated as well as the unphosphorylated form of Pol II the enzyme. The concentration of antibodies used for immunoprecipitations was 2 µl/ml

Transfection, microscopy and RNA preparation

HeLa cells were grown to 70–90% confluence and transfected with 0.4 mg of plasmid per cm2 of culture dish using Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions. After 24 h, fluorescence was monitored with AxioObserver Z1 microscope coupled to AxioCam MRm (Carl Zeiss MicroImaging) and RNA was extracted with TRI Reagent (Sigma).

Northern blot

Total RNA was separated on a 0.8% agarose gel containing 6.7% formaldehyde, capillary-blotted onto a Hybond-XL membrane (GE Healthcare) and UV-crosslinked. 32P-labeled DNA probe was hybridized in ULTRAhyb-Oligo Buffer (Ambion) at 42°C overnight. The probe was 5ʹ-labeled with T4 PNK (NEB).

Flow cytometry

GFP-positive cells were quantified by FACSCalibur (BD Biosciences) and data were analyzed in Cyflogic (CyFlo Ltd, Finland) and SPSS (IBM) software. From each sample, fluorescence of 10,000 cells was measured and only GFP-positive events, as determined by mock-transfected cell fluorescence, were taken into account.

Poly(A) fractionation

150 pmol biotinylated Oligo(dT) (Promega) was bound for 10 min at room temperature to 0.6 ml MagneSphere® magnetic beads (Promega) prepared according to manufacturer’s instructions. 80 mg of total RNA was denatured at 65°C, 10 min, chilled on ice for 5 min and mixed with Oligo(dT)-beads solution. After 10 min incubation at room temperature, the beads were washed six times and Poly(A)+ RNA was eluted according to manufacturer’s instructions. Before washing of the beads, the first supernatant was taken as Poly(A)-RNA. Both fractions were ethanol-precipitated.

RT-PCR and RT-qPCR

Two milligrams of total RNA or 200 ng of Poly(A)-fractionated RNA was denatured with 200 pmol of random nonamers (Sigma) at 70°C for 10 min. The reaction was split in two, one without reverse transcriptase as a control. RT was performed at 45°C for 90 min using OmniScript (Qiagen). 1/40 of the total reaction was used for PCR and approximately 1/30 was used per qPCR well. qPCR was performed in Mastercycler® realplex (Eppendorf) with HOT FIREPol® qPCR Mix (Medibena) and primers specified in Supplementary Table S1. Transfection was controlled for by normalizing expression values to neo and subsequently all amplicons were normalized to GFP 1.

Sequence alignment

ACRO1 translation was aligned globally against a fragment of human Pol II CTD of equivalent length via Needleman-Wunsch algorithm as implemented in Expasy lalign [43] using BLOSUM62 scoring matrix [44], opening gap penalty of −12 and extending gap penalty of −2.

Analysis of amino acid enrichment

The statistical significance of the enrichment of Pol II CTD amino acids in translated RAPs was evaluated by an analysis of random RNA sequences generated computationally using background frequencies of the four RNA nucleotides in the entire human genome. For the complete set of RAPs identified in this study, 106 sets of random RNA sequences of equivalent lengths were generated. Each set was then translated using the universal genetic code and the Jensen–Shannon divergence (JSD) between the distribution of the obtained amino-acid frequencies and the distribution of amino-acid frequencies in human Pol II CTD was determined. The p-value was determined by comparing the distribution of JSD values in the case of random sequences against the RAP-Pol II CTD JSD. The RAP-Pol II CTD JSD was over 10 standard deviations lower than the average random-sequence JSD, yielding an estimated p-value < 10−23. As different amino acids are encoded by a different number of codons, the above analysis was performed by first normalizing the amino-acid frequencies in translated RAPs and random RNA sequences or Pol II CTD by the respective number of codons in the universal genetic code.

Accession numbers

The ACRO1 sequence used in the reporter assay has been deposited in the Genbank with the number GenBank KF726396. The raw data are available for download on the Sequence Read Archive under BioProject accession PRJNA616423. Click here for additional data file.
  43 in total

1.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 2.  Structure of eukaryotic RNA polymerases.

Authors:  P Cramer; K-J Armache; S Baumli; S Benkert; F Brueckner; C Buchen; G E Damsma; S Dengl; S R Geiger; A J Jasiak; A Jawhari; S Jennebach; T Kamenski; H Kettenberger; C-D Kuhn; E Lehmann; K Leike; J F Sydow; A Vannini
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

3.  Libraries for genomic SELEX.

Authors:  B S Singer; T Shtatland; D Brown; L Gold
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

Review 4.  The Properties of Long Noncoding RNAs That Regulate Chromatin.

Authors:  Michael Rutenberg-Schoenberg; Alec N Sexton; Matthew D Simon
Journal:  Annu Rev Genomics Hum Genet       Date:  2016-04-21       Impact factor: 8.929

5.  Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers.

Authors:  David T Ting; Doron Lipson; Suchismita Paul; Brian W Brannigan; Sara Akhavanfard; Erik J Coffman; Gianmarco Contino; Vikram Deshpande; A John Iafrate; Stan Letovsky; Miguel N Rivera; Nabeel Bardeesy; Shyamala Maheswaran; Daniel A Haber
Journal:  Science       Date:  2011-01-13       Impact factor: 47.728

Review 6.  Getting up to speed with transcription elongation by RNA polymerase II.

Authors:  Iris Jonkers; John T Lis
Journal:  Nat Rev Mol Cell Biol       Date:  2015-02-18       Impact factor: 94.444

Review 7.  Origin and evolution of the genetic code: the universal enigma.

Authors:  Eugene V Koonin; Artem S Novozhilov
Journal:  IUBMB Life       Date:  2009-02       Impact factor: 3.885

8.  Nascent RNA signaling to yeast RNA Pol II during transcription elongation.

Authors:  Eva Klopf; Murielle Moes; Fabian Amman; Bob Zimmermann; Frederike von Pelchrzim; Christina Wagner; Renée Schroeder
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

9.  B2 RNA binds directly to RNA polymerase II to repress transcript synthesis.

Authors:  Celso A Espinoza; Tiffany A Allen; Aaron R Hieb; Jennifer F Kugel; James A Goodrich
Journal:  Nat Struct Mol Biol       Date:  2004-08-08       Impact factor: 15.369

10.  Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock.

Authors:  Peter D Mariner; Ryan D Walters; Celso A Espinoza; Linda F Drullinger; Stacey D Wagner; Jennifer F Kugel; James A Goodrich
Journal:  Mol Cell       Date:  2008-02-29       Impact factor: 17.970

View more
  1 in total

1.  Differential enrichment of H3K9me3 at annotated satellite DNA repeats in human cell lines and during fetal development in mouse.

Authors:  Tanja Vojvoda Zeljko; Đurđica Ugarković; Željka Pezer
Journal:  Epigenetics Chromatin       Date:  2021-10-18       Impact factor: 4.954

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.